PCYLINK™
Pre-seed neurotechnology · $2.0M Pre-Seed Round

Secure neural connectivity, designed around human agency.

PCYLINK™ is a preclinical-stage company developing a privacy-first neural device mesh for people and the devices they rely on. The work ahead is a validation roadmap from thesis to evidence.

Calm profile with soft neural mesh linking phone, home, and vehicle interfaces
Pre-Seed stage

Preclinical research and engineering

Disciplined framing — thesis first, evidence next.

Validation roadmap

Milestone-driven path to evidence

In silico → organ-on-chip → preclinical gates → human pathway only after gates are met.

Privacy by design

Security and agency at every layer

Neurodata treated as an encrypted personal asset. Networking isolated from life-support functions.

Thesis

The interface should disappear.

Familiar endpoints — phone, PC, home, vehicle — without crude implants or external charging packs. Same-day outpatient design intent: link neural architecture to a secure device mesh while keeping the person in control.

What we’re building

A minimally invasive Brain-Computer Interface: Nanostructure Injection establishing an Interlinking Node Array (INA), powered by bio-geobattery catalysis from cerebrospinal fluid, secured with AES-256 and Neural-Ephemeral Key Exchange (NEKE).

See the technology — NeuraSense
Neural mesh connecting to secured devices

Validation path

01 · In silico

Model first

Model catalyst behaviour, resonance, and the proposed security layer.

02 · Organ-on-chip

Stress-test

Stress-test proposed power and encapsulation concepts.

03 · Preclinical

Evaluate

Evaluate anchoring, migration, and metabolic coupling.

04 · Human pathway

Only after gates

Advance only after preclinical gates are met.

Medical & disability · addressable need

Independence when hands or voice are unavailable

Assistive thesis for people living with ALS, spinal cord injury, paralysis, or locked-in syndromes: dignity-preserving communication and device control — messaging, browsing, home / IoT — without relying on fatigue-heavy switch scanning or eye-gaze alone. Caregiver burden and outpatient access matter as much as raw bit-rate.

Communication & control

Intent-speed pathways toward messaging, screens, and assistive device control when motor pathways fail.

Outpatient vs. surgery barrier

Designed around a minimally invasive release model — contrasting with invasive implant + long recovery pathways that limit access.

Independence & caregivers

Digital independence at home — reducing friction for users and those who support them.

Core technology

Nanostructure Injection

Proprietary delivery via the brainstem establishes an Interlinking Node Array (INA) across key cortical areas — designed for outpatient release.

Bio-geobattery power

Proprietary catalysis generates electrochemical energy from cerebrospinal fluid, keeping the link active without external charging.

Secure device mesh

High-bandwidth, low-latency connectivity that treats the brain as a primary node across phones, PCs, vehicles, and home / IoT.

AES-256 + NEKE

Every handshake between brain and device mesh is unique and user-authenticated. Neurodata stays an encrypted personal asset.

Isolated networking

Networking functions are isolated from biological life-support functions to help protect autonomy at the hardware layer.

Founder

Kean A. Morton

Founder-led deep-tech neurotechnology. Building PCYLINK as a disciplined preclinical-stage company — privacy-first, human-agency-first — with an assistive path for independence when hands or voice are unavailable.

Explore